Iwahashi Y - Search Results

1

Concurrent Therapy with a Low-carbohydrate Diet and Miglitol Remarkably Improved the Postprandial Blood Glucose and Insulin Levels in a Patient with Reactive Hypoglycemia due to Late Dumping Syndrome.

Hirose S, Iwahashi Y, Seo A, Sumiyoshi M, Takahashi T, Tamori Y. Hirose S, et al. Among authors: iwahashi y. Intern Med. 2016;55(9):1137-42. doi: 10.2169/internalmedicine.55.5655. Epub 2016 May 1. Intern Med. 2016. PMID: 27150868 Free article.

2

Impact of the 8-week Administration of Tofogliflozin for Glycemic Control and Body Composition in Japanese Patients with Type 2 Diabetes Mellitus.

Hirose S, Nakajima S, Iwahashi Y, Seo A, Takahashi T, Tamori Y. Hirose S, et al. Among authors: iwahashi y. Intern Med. 2016;55(22):3239-3245. doi: 10.2169/internalmedicine.55.6367. Epub 2016 Nov 15. Intern Med. 2016. PMID: 27853064 Free PMC article.

3

Evaluation of metabolic parameters and body composition in Japanese patients with type 2 diabetes mellitus who were administered tofogliflozin for 48 weeks.

Iwahashi Y, Hirose S, Nakajima S, Seo A, Takahashi T, Tamori Y. Iwahashi Y, et al. Diabetol Int. 2016 Nov 11;8(2):205-211. doi: 10.1007/s13340-016-0295-6. eCollection 2017 Jun. Diabetol Int. 2016. PMID: 30603323 Free PMC article.

4

Fat-specific protein 27α inhibits autophagy-dependent lipid droplet breakdown in white adipocytes.

Nakajima S, Nishimoto Y, Tateya S, Iwahashi Y, Okamatsu-Ogura Y, Saito M, Ogawa W, Tamori Y. Nakajima S, et al. Among authors: iwahashi y. J Diabetes Investig. 2019 Nov;10(6):1419-1429. doi: 10.1111/jdi.13050. Epub 2019 Apr 26. J Diabetes Investig. 2019. PMID: 30927519 Free PMC article.

5

Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism.

Hirata Y, Fukuoka H, Iguchi G, Iwahashi Y, Fujita Y, Hari Y, Iga M, Nakajima S, Nishimoto Y, Mukai M, Hirota Y, Sakaguchi K, Ogawa W, Takahashi Y. Hirata Y, et al. Among authors: iwahashi y. Eur J Endocrinol. 2015 Aug;173(2):247-56. doi: 10.1530/EJE-15-0130. Epub 2015 May 20. Eur J Endocrinol. 2015. PMID: 25994949

6

Histopathologic Comparison Among Drug Eruptions Induced by Enfortumab Vedotin, Brentuximab Vedotin, and Taxanes.

Iwahashi Y, Goto K, Ohe S, Bun S, Kido K, Matsui T, Morii E, Honma K. Iwahashi Y, et al. Am J Dermatopathol. 2024 Dec 31. doi: 10.1097/DAD.0000000000002911. Online ahead of print. Am J Dermatopathol. 2024. PMID: 39787333

7

Escalating the dose of high-dose-rate brachytherapy combined with external beam radiotherapy improves the disease control rate in patients with high- or very-high-risk prostate cancer.

Inagaki T, Noda Y, Iwahashi Y, Naka T, Kojima M, Inagaki R, Shimono R, Awaya A, Kohjimoto Y, Hara I, Sonomura T. Inagaki T, et al. Among authors: iwahashi y. Brachytherapy. 2024 Dec 31:S1538-4721(24)00442-2. doi: 10.1016/j.brachy.2024.10.011. Online ahead of print. Brachytherapy. 2024. PMID: 39743419

8

Non-contrast CT attenuation value of renal papilla is a novel predictor of recurrence in kidney stone disease.

Kohjimoto Y, Yamashita S, Iwahashi Y, Deguchi R, Wakamiya T, Hara I. Kohjimoto Y, et al. Among authors: iwahashi y. BMC Urol. 2024 Dec 23;24(1):279. doi: 10.1186/s12894-024-01657-8. BMC Urol. 2024. PMID: 39710663 Free PMC article.

9

Comparison of Prognosis and Health-Related Quality of Life Between Robot-Assisted Radical Prostatectomy Versus High-Dose-Rate Brachytherapy Combined With External Beam Radiation Therapy and Hormone Therapy for High-Risk Prostate Cancer.

Iwahashi Y, Wakamiya T, Kawabata H, Deguchi R, Muraoka S, Inagaki T, Noda Y, Yamashita S, Kohjimoto Y, Sonomura T, Hara I. Iwahashi Y, et al. Prostate. 2024 Dec 5. doi: 10.1002/pros.24831. Online ahead of print. Prostate. 2024. PMID: 39639423

10

Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer.

Tsukaguchi A, Tamiya A, Fukuda S, Iwahashi Y, Kanaoka K, Tanaka Y, Inagaki Y, Taniguchi Y, Nakao K, Kagawa T, Matsuda Y, Okishio K. Tsukaguchi A, et al. Among authors: iwahashi y. Anticancer Res. 2024 Oct;44(10):4517-4524. doi: 10.21873/anticanres.17280. Anticancer Res. 2024. PMID: 39348997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters